ALISON J. NATHAN, United States District Judge.
Before the Court is a motion by non-party Nasdaq, Inc. ("Nasdaq") to quash a subpoena duces tecum issued pursuant to Federal Rule of Criminal Procedure 17(c) upon the ex parte application of Defendant Benjamin Wey. For the reasons set forth below, Nasdaq's motion is DENIED.
Defendant Wey is charged in an eight-count indictment returned on September 8, 2015. Dkt. No. 2 (the "Indictment"). The Indictment alleges that between approximately 2007 and 2011 Wey, along with co-Defendant Seref Dogan Erbek and unindicted co-conspirators known and unknown, orchestrated a scheme by which Wey — through various non-party entities, family members, and associates (the "Nominees") — covertly amassed beneficial ownership of substantial portions of the equity stock of several publicly traded companies (the "Issuers"), manipulated the market price of the Issuers' stock, liquidated his holdings at artificially inflated prices, and then laundered millions of dollars in ill-gotten proceeds. See, e.g., Indictment ¶¶ 7, 13, 18-22.
Specifically, the Indictment alleges that Wey caused the Nominees to acquire on his behalf substantial portions of the shares of certain U.S.-based over-the-counter-traded shell companies and then, through his consulting firm New York Global Group, Inc. and its alleged affiliate in Beijing, facilitated "reverse merger" transactions whereby China-based operating companies merged into those shell companies, thus forming new publicly traded corporations — the Issuers. Id. ¶¶ 8-12. According to the Indictment, the Nominees acquired and retained, for Wey's undisclosed benefit, stock in the Issuers by virtue of their ownership of the target shell companies, with these Wey-controlled holdings together constituting more than five percent of the Issuers' outstanding shares. Id. ¶¶ 7, 11-14.
Wey then proceeded, the Indictment alleges, to manipulate the demand for and price of Issuer stock. Id. ¶¶ 15-19. Critical to that purported manipulation scheme — and pertinent to the instant motion — was an effort, allegedly directed or otherwise orchestrated by Wey, to secure listings on the Nasdaq Stock Market (a U.S.-based securities exchange owned and operated by movant Nasdaq) for several of the Issuers, including SmartHeat, Inc. ("SmartHeat"), Deer Consumer Products, Inc. ("Deer"), and CleanTech Innovations, Inc. ("CleanTech"), so that their shares could be traded in greater volumes and in more liquid markets. Id. ¶ 15. As part of that effort, Wey allegedly engaged in "deception" of Nasdaq, facilitating the Issuers' satisfaction of Nasdaq's 300 "round-lot" shareholder requirement — that is, the requirement that all listed issuers have at least 300 shareholders owning at least 100 shares of common stock each — by artificially inflating the Issuers' investor bases
Wey is scheduled for trial in October 2017 on charges of securities fraud, wire fraud, conspiracy to commit securities and wire fraud, failure to disclose beneficial ownership of Deer and CleanTech, and money laundering. Id. ¶¶ 23-40. In September 2016, Wey submitted an ex parte application for the issuance, pursuant to Federal Rule of Criminal Procedure 17(c), of subpoenas duces tecum directed to several non-parties, including Nasdaq. The proposed subpoena to Nasdaq sought:
September 2, 2016 Declaration of David M. Siegal, Ex. C Att. A. In a Sealed Ex Parte Order dated September 20, 2016 (the "September 20 Order"), the Court denied Wey's application, concluding, as to the requested Nasdaq subpoena, that Wey had not identified the documents sought with the requisite specificity and had failed to make the necessary showing that all requested documents would be admissible at trial. September 20 Order at 5-7. The September 20 Order did, however, afford Wey leave to renew his application and make a proper showing that each requirement for issuing a Rule 17(c) subpoena was satisfied. Id. at 8. It also granted Wey's request to allow the application to proceed ex parte, citing its disclosure of certain elements of the defense's trial strategy. Id. at 2.
On December 7, 2016, Wey, again proceeding ex parte, renewed his motion. The revised application substantially narrowed the set of documents sought, limiting it to:
December 7, 2016 Declaration of David M. Siegal, Ex. C, Att. A. It also set forth anticipated bases for admission of the documents at trial through several specific exceptions to the hearsay rule. See Memorandum of Law in Support of Defendant Benjamin Wey's Renewed Ex Parte Motion for the Issuance of Rule 17(c) Subpoenas at 25. In another Sealed Ex Parte Order dated December 15, 2016 (the "December 15 Order"), the Court granted the renewed motion, concluding that Wey had "address[ed] and allay[ed]" the concerns, articulated in the September 20 Order, regarding the specific identification and likely admissibility of the targeted Nasdaq documents. December 15 Order at 2-3.
On February 3, 2017, Nasdaq filed the instant motion to quash. Dkt. Nos. 89-90. Nasdaq represents in its moving papers that it is "ready and willing to produce many of the requested documents as a compromise," including "all documents responsive to the [S]ubpoena that Nasdaq sent to, or received from, the Issuers," but otherwise "objects to the [S]ubpoena because it seeks disclosure of confidential investigative and deliberative records related to particular issuers' applications for listing on Nasdaq's exchange." Memorandum in Support of Motion to Quash Third-Party Subpoena Directed to Nasdaq, Inc., Dkt. No. 90 ("Br."), at 1, 3 n.1. Wey opposes Nasdaq's motion. Dkt. No. 98. The Government has made no submission concerning this dispute.
Nasdaq asserts three arguments in support of its motion to quash. First, it contends that its subsidiary Nasdaq Stock Market, which owns and controls the documents at issue, is a self-regulatory organization, and, accordingly, enjoys absolute immunity from discovery. Second, it avers that the documents are protected from disclosure by the deliberative process, law enforcement, and investigative privileges. And third, it argues that the Subpoena, even in its revised form, fails to satisfy the requirements of Rule 17(c). Br. at 3-4. The Court will address each argument in turn.
Nasdaq Stock Market is undisputedly a national stock exchange registered with the Securities Exchange Commission ("SEC") and thus, by statute, a self-regulatory organization ("SRO") with attendant regulatory, enforcement, and adjudicatory authority subject to SEC approval and oversight. See In the Matter of the Application of Nasdaq Stock Market LLC for Registration as a National Securities Exchange, Exchange Act Release No. 34-53128, 2006 WL 92913 (Jan. 13, 2006); 15 U.S.C. §§ 78c(a)(26), 78f, 78s(b); see also Lanier v. Bats Exchange, Inc., 838 F.3d 139, 143 (2d Cir. 2016) (recognizing "considerable authority" of SROs like Nasdaq Stock Market). Nasdaq asserts that by virtue of its subsidiary's status as an SRO, it enjoys "`absolute immunity'" when "`acting under the aegis of [its] regulatory duties.'" Br. at 4 (additional internal quotation marks and emphasis omitted) (quoting DL Capital Grp., LLC v. Nasdaq Stock Market, Inc., 409 F.3d 93, 97 (2d Cir. 2005)). That immunity, Nasdaq contends, broadly shields it from the "`burdens of litigation, including discovery,'" and thus excuses it altogether from compliance with subpoenas, including the one at issue. Br. at 4 (quoting In re Barclays Liquidity Cross & High Frequency Trading Litig., 126 F.Supp.3d 342, 355 (S.D.N.Y. 2015)). Such protection is particularly appropriate here, according to Nasdaq, because Wey "seeks disclosure of records and communications concerning Nasdaq's enforcement of a listing standard" — "material at the heart of Nasdaq's regulatory responsibilities." Br. at 5. The Court is not persuaded.
There is no question that SROs are generally "entitled to absolute immunity from private damages suits in connection with discharge of their responsibilities." Standard Inv. Chartered, Inc. v. Nat'l Ass'n of Sec. Dealers, Inc., 637 F.3d 112, 115 (2d Cir. 2011). That immunity, as characterized by the Court of Appeals, is analogous to — but independent of — the "sovereign immunity from all suits for money damages" enjoyed by "government agencies, including the SEC." Barbara v. N.Y. Stock Exch., 99 F.3d 49, 59 (2d Cir.
It is further beyond dispute that at least the sovereign immunity enjoyed in the first instance by government agencies themselves has been recognized as shielding them — absent waiver of the sort found in the Administrative Procedure Act ("APA") — from enforcement of subpoenas duces tecum in civil suits to which the United States is not a party. See U.S. Envtl. Prot. Agency v. Gen. Elec. Co., 197 F.3d 592, 597-99 (2d Cir. 1999) (recognizing that enforcement of third-party subpoena issued by civil defendant would "compel" federal agency "to act" and would therefore be "barred by sovereign immunity" but for the express waiver set forth in the APA), opinion amended in part on rehearing, 212 F.3d 689 (2000).
But it does not necessarily follow from either premise — that is, from SROs' quasi-sovereign immunity to civil suits for damages or from federal agencies' sovereign immunity to third-party civil subpoenas — that Nasdaq is, as it urges, categorically excused from compliance with defense subpoenas endorsed by federal courts in the far different context of criminal proceedings. The latter is a proposition for which Nasdaq offers
The Court of Appeals has expressly "cautioned" that the doctrine of absolute immunity for SROs "`is of a rare and exceptional character,'" and, accordingly, that "courts must examine the invocation of absolute immunity on a case by case basis," with the "party asserting immunity bear[ing] the burden of demonstrating its entitlement." Standard Inv. Chartered, 637 F.3d at 115-116 (internal citation omitted) (quoting Barrett v. United States, 798 F.2d 565, 571 (2d Cir. 1986)). Nasdaq fails to carry its burden in this case. In contrast to civil lawsuits, "[t]he right to the production of all evidence at a criminal trial," as the Supreme Court recognized more than forty years ago, "has constitutional dimensions" under the Fifth and Sixth Amendments, and it "is the manifest duty of the courts to vindicate those guarantees" by ensuring "that all relevant and admissible evidence be produced." United States v. Nixon, 418 U.S. 683, 711, 94 S.Ct. 3090, 41 L.Ed.2d 1039 (1974). In light of those principles, the Supreme Court has (famously) held that executive privilege — a protection that, while distinct from SRO immunity, shares in part its basis in concern for the "effective discharge" of government powers — "cannot prevail over the fundamental demands of due process of law in the fair administration of criminal justice," at least when the assertion of privilege is "based only on the generalized interest in confidentiality." Id. at 711-13, 94 S.Ct. 3090. Accordingly, even the President of United States is not entirely shielded from compliance with criminal subpoenas that satisfy the requirements of Rule 17(c). Id. at 707-13, 94 S.Ct. 3090 (noting that "it is imperative to the function of the courts that compulsory process be available for the production of evidence needed either by the prosecution or by the defense" and that "the ends of criminal justice would be defeated if judgments were to be founded on a partial or speculative presentation of the facts").
Similarly, and with perhaps even closer parallels to the instant scenario, several courts have responded to claims of sovereign immunity from subpoenas asserted by third-party Indian tribes by recognizing judicial "discretion not to apply the [immunity] doctrine" — which is "largely" a matter of "comity" — if "it would conflict with more important federal interests, such as the constitutional rights of criminal defendants." Alltel Commc'ns, LLC v. DeJordy, 675 F.3d 1100, 1105 (8th Cir. 2012) (considering tribal immunity claim and contrasting question in criminal context with the "question [of] whether the [sovereign immunity] doctrine applies to non-party subpoenas served in ... private civil litigation," where no "competing federal interests are present other than the general benefits of discovery"); see also United States v. Juvenile Male 1, 431 F.Supp.2d 1012, 1016-19 (D. Ariz. 2006) (denying motion to quash criminal defendant's subpoena because court could not permit "tribe's immunity from civil actions" to "interfer[e] with the defendant's right to compulsory process"); United States v. Velarde, 40 F.Supp.2d 1314, 1316-17 (D.N.M. 1999) ("I also conclude that the Court's interest in protecting Defendant's constitutional rights justifies an intrusion upon tribal sovereignty in order to enforce a subpoena on behalf of Defendant."), conviction vacated on other grounds, 214 F.3d 1204 (10th Cir. 2000); United States v. Snowden, 879 F.Supp. 1054, 1057-58 (D. Or. 1995) (concluding that criminal defendant's "constitutional rights of due process, fair trial, confrontation, and compulsory process outweigh [Indian tribe's] claim of immunity" from defendant's subpoena).
Here, Wey seeks to counter at least one substantive component of the Government's
Nor do the few cases relied upon by Nasdaq convince the Court otherwise. Nasdaq cites the Second Circuit's decision in D'Alessio for, it would seem, the proposition that an SRO is absolutely immune even from an action initiated by a "criminal defendant." Reply in Support of Motion to Quash Third-Party Subpoena Directed to Nasdaq, Inc., Dkt. No. 102 ("Reply"), at 4-5. The plaintiff in D'Alessio had indeed been indicted on charges stemming from a trading scheme executed during his time as a floor broker on the New York Stock Exchange. 258 F.3d at 97. But those charges had been dismissed before the plaintiff brought the lawsuit from which the Exchange was ultimately adjudged immune: civil tort suit for compensatory and punitive damages, with none of the Fifth or Sixth Amendment implications present here. Id. at 97-98. And the Court of Appeals held only that the absolute immunity doctrine is not, as the plaintiff would have it, "limit[ed]... to cases involving [an SRO's] misconduct in connection with disciplinary proceedings" but shields SROs from any "suit for conduct falling within the scope of [their] regulatory and general oversight functions." Id. at 105-06 (also noting that, as a result, "absolute immunity precludes D'Alessio from recovering money damages in connection with his claims") (all emphasis added). Nasdaq's immunity from civil suit, or burdens associated with civil litigation, is simply not at issue in this case.
Smith v. Cromer, 159 F.3d 875 (4th Cir. 1998), a Fourth Circuit decision, is invoked for the somewhat blithe assertion that "courts regularly quash subpoenas in criminal cases on sovereign immunity grounds." Reply at 5. Smith, and the cases it discusses, do make clear that sovereign immunity precludes state courts, and, correspondingly, federal courts sitting in removal jurisdiction, from compelling federal agencies to produce documents or witnesses in violation of their own duly promulgated regulations. See 159 F.3d at 879-81. The cases make equally clear, however, that because the APA includes a waiver of the federal government's sovereign immunity to requests for non-damages relief in federal court, "federal-court litigant[s]" can, under certain circumstances, "seek to obtain documents from a federal agency by means of a federal subpoena." See Houston Bus. Journal, Inc. v. Office of the Comptroller of the Currency, U.S. Dep't of the Treasury, 86 F.3d 1208, 1211-12 (D.C. Cir. 1996) (explaining that "[w]hen a litigant seeks to obtain documents from a non-party federal government agency, the procedure varies depending on whether the underlying litigation is in federal or in state court" and that while sovereign immunity divests both state courts and federal courts following removal of subject matter jurisdiction to compel production, in "federal court, the federal government
Finally, there is United States v. James, a 1992 decision from the Ninth Circuit. The James court did recognize that an Indian tribe enjoyed sovereign immunity, based on "its status as a dependent domestic nation," from a third-party subpoena issued on the application of a criminal defendant (before noting that, at least to certain categories of requested documents, the tribe had waived that immunity). 980 F.2d 1314, 1319-20 (9th Cir. 1992). But, as several courts both inside and outside of the Ninth Circuit have since recognized, James' abbreviated discussion of the issue failed even to acknowledge the constitutional interests at stake given the posture of the underlying matter. See, e.g., Alltel, 675 F.3d at 1105 (recognizing that James has been "criticized and distinguished in district court opinions" that have "concluded that the Sixth Amendment rights of criminal defendants," among other things, "counsel against such a broad interpretation of tribal immunity"); Velarde, 40 F.Supp.2d at 1315-17 ("I reject the overly simplistic analysis of James."); Snowden, 879 F.Supp. at 1056-58 (denying tribe's motion to quash and noting that "James does not control because the defendant did not raise constitutional challenges to the claim of immunity"). The Court is aware of no decision from this Circuit relying on James to quash a third-party subpoena issued by a criminal defendant to any entity — sovereign, quasi-sovereign, or otherwise — and it sees no reason to do so here.
There is no doubt that quashing the Subpoena under the circumstances presented would, at least to some degree, impair Wey's Fifth and Sixth Amendment rights. In the absence of authoritative legal
Nasdaq next argues that the documents targeted by the Subpoena are privileged and therefore protected from disclosure. Specifically, Nasdaq invokes the deliberative process, law enforcement, and investigative privileges.
The deliberative process, law enforcement, and investigative privileges share certain features, particularly with respect to the procedural requirements for their formal assertion.
"The deliberative process privilege protects from disclosure `documents reflecting advisory opinions, recommendations and deliberations comprising part of a process by which governmental decisions and policies are formulated.'" In re Methyl Tertiary Butyl Ether Prods. Liability Litig. ("In re MTBE"), 643 F.Supp.2d 439, 441 (S.D.N.Y. 2009) (additional internal quotation marks omitted) (quoting Nat'l Council of La Raza v. Dep't of Justice, 411 F.3d 350, 356 (2d Cir. 2005)). "[A] sub-species of work-product privilege," it exists "to enhance the quality of agency decisions, by protecting open and frank discussion among those who make them within the Government." Tigue v. U.S. Dep't of Justice, 312 F.3d 70, 76 (2d Cir. 2002) (internal quotation marks omitted). The deliberative process privilege "does not provide a blanket basis upon which to withhold documents that an agency has created during its decision-making process," because such a rule "would provide an exemption from the discovery rules for decision-making agencies generally," which, "of course, is not the law." Toney-Dick v. Doar, 12-cv-9162, 2013 WL 5549921, at *1 (S.D.N.Y. Oct. 3, 2013). Rather, the privilege applies only "when a document is `(1) predecisional, i.e., prepared in order to assist an agency decisionmaker in arriving at his decision, and (2) deliberative, i.e., actually related to the process by which policies are formulated.'" Schomburg v. N.Y.C. Police Dep't, 298 F.R.D. 138, 144 (S.D.N.Y. 2014) (internal alterations omitted) (quoting La Raza, 411 F.3d at 356). It does not extend to "purely factual information regarding, for example, investigative matters or factual observations." MacNamara v. City of N.Y., 249 F.R.D. 70, 78 (S.D.N.Y. 2008) (internal quotation marks omitted) (citing, inter alia, Grand Cent. P'ship, Inc. v. Cuomo, 166 F.3d 473, 482 (2d Cir. 1999)). "Thus, factual findings and conclusions, as opposed to opinions and recommendations, are not protected." E.B. v. N.Y.C. Bd. of Educ., 233 F.R.D. 289, 292 (E.D.N.Y. 2005) (internal quotation marks and citation omitted).
The deliberative process privilege is a qualified privilege, and, as such, "when the existence of the privilege is established, there is a need to balance the public interest in nondisclosure against the need of the particular litigant for access to the privileged information." In re MTBE, 643 F.Supp.2d at 442 (internal quotation marks and brackets omitted).
The purpose of the law enforcement privilege is "`to prevent disclosure of law enforcement techniques and procedures, to preserve the confidentiality of sources, to protect witness and law enforcement personnel, to safeguard the privacy of individuals involved in an investigation, and otherwise to prevent interference with an investigation."' In re the City of N.Y., 607 F.3d 923, 940-42 (2d Cir. 2010) (quoting In re Dep't of Investigation of City of N.Y., 856 F.2d 481, 484 (2d Cir. 1988)). The Court of Appeals has expressly "adopt[ed] the holding of the District of Columbia Circuit that the party asserting the law enforcement privilege bears the burden of showing that the privilege applies to the documents in question." In re the City of N.Y., 607 F.3d at 944 (citing In re Sealed Case, 856 F.2d 268, 271-72 (D.C. Cir. 1988)). To carry that burden, the asserting party must meet three procedural requirements substantially similar to those applicable to the deliberative process privilege: "(1) there must be a formal claim of privilege by the head of the department having control over the requested information; (2) assertion of the privilege must be based on actual personal consideration by that official; and (3) the information for which the privilege is claimed must be specified, with an explanation why it properly falls within the scope of the privilege." In re Sealed Case, 856 F.2d at 271-72. With the respect to third prong, "the party asserting the law enforcement privilege must show that the documents contain information that the law enforcement privilege is intended to protect." In re the City of N.Y., 607 F.3d at 944.
The law enforcement privilege, like the deliberative process privilege, is not absolute, but "[o]nce a court has determined that the law enforcement privilege applies ... `there ought to be a pretty strong presumption against lifting the privilege.'" In re the City of N.Y., 607 F.3d at 945 (quoting Dellwood Farms, Inc. v. Cargill, Inc., 128 F.3d 1122, 1125 (7th Cir. 1997)). "To rebut that presumption, the party seeking disclosure must show (1) that its suit is `non-frivolous and brought in good faith,' (2) that `the information sought is [not] available through other discovery or from other sources,' and (3) that the information sought is `importan[t]' to the party's case." Id. (brackets in original) (quoting Friedman v. Bache Halsey Stuart Shields, Inc., 738 F.2d 1336, 1343 (D.C. Cir. 1984)). In assessing "both the applicability of the privilege and the need for the documents," the district court must ordinarily review the documents in question." Id. at 948.
Finally, to the extent that it constitutes a privilege distinct from the related law enforcement privilege, several courts in this District have recognized that the "investigatory materials of ... non-governmental self-regulating bodies may, in some respects, be subject to a qualified privilege upon competent proof of harm if the documents are disclosed." S.E.C. v. Thrasher, 92-cv-6987, 1995 WL 46681, at *12 (S.D.N.Y. Feb. 7, 1995). The basis for that privilege is "the public interest in preserving the ability of self-regulatory bodies to function effectively." DGM Invs., Inc. v. N.Y. Futures Exch., 224 F.R.D. 133, 140 (S.D.N.Y. 2004). The privilege has been applied, for example, to investigatory materials pertaining to "ongoing disciplinary proceeding[s] by a non-governmental entity," DGM Invs., 224 F.R.D. at 138-141, as well as to materials whose protection is deemed "necessary to encourage both members and non-members of [an SRO] to cooperate with its statutorily required internal investigations," Apex Oil Co. v. DiMauro, 110 F.R.D. 490, 496-97 (S.D.N.Y. 1985); see also Ross v. Bolton, 106 F.R.D. 22, 23-25 (S.D.N.Y. 1985).
As with the privileges discussed above, "[t]here are three prerequisites to the assertion of the [investigatory] privilege: (i) the head of the department having control over the information requested must assert the privilege; (ii) the official in question must do so based on actual personal consideration; and (iii) he or she must specify the information purportedly
With relevance to each of these three privileges, the Supreme Court has generally recognized that "evidentiary privileges must be construed narrowly because [they] impede the search for truth." Pierce Cty., Wash v. Guillen, 537 U.S. 129, 144-45, 123 S.Ct. 720, 154 L.Ed.2d 610 (2003); see also Nixon, 418 U.S. at 709-10, 94 S.Ct. 3090 ("privileges against forced disclosure," whether "established in the Constitution, by statute, or at common law," are "exceptions to the demand for every man's evidence" and "are not lightly created nor expansively construed, for they are in derogation of the search for truth"); United States v. Int'l Bd. of Teamsters, 119 F.3d 210, 214 (2d Cir. 1997) (a privilege "ought to be strictly confined within the narrowest possible limits consistent with the logic of its principle") (internal quotation marks omitted). "The party asserting the privilege" generally "bears the burden of proof" as to the propriety of its application. In re Grand Jury Subpoena, 218 F.Supp.2d at 553.
Nasdaq's assertion of each of these privileges is both procedurally improper and substantively lacking. Nasdaq has not even attempted to make an evidentiary showing of its need to invoke any privilege with respect to the materials at issue. It has submitted no supporting affidavits or other competent proof, instead relying entirely on ipse dixit assertions — all by counsel — that disclosure of the documents targeted by the Subpoena would work vague and generalized harm on Nasdaq's ability to enforce its listing requirements, investigate delinquent issuers, and generally "discharg[e] [its] regulatory responsibilities." Br. at 7-9. Such assertions, somewhat surprisingly, are submitted without any accompanying description of the documents themselves (or offer of submission for in camera review), without any specific explanation of the need for their protection, and without any indication that they have been personally reviewed — and their privilege status considered — by the head of the SRO or a duly designated subordinate. Quite simply, on the record (or lack thereof) before it, the Court cannot make appropriate privilege determinations and thus cannot quash the Subpoena on privilege grounds.
Finally, Nasdaq urges that the Subpoena contravenes Rule 17(c) because the documents that it seeks are insufficiently relevant to warrant admission at trial and, in any event, are procurable through means other than the Subpoena. Br. at 9-11. The Court disagrees.
As discussed in the September 20 and December 15 Orders, a party seeking the issuance of a subpoena under Rule 17(c) must satisfy the requirements set forth by the Supreme Court in Nixon. In particular, the party must demonstrate the materials targeted by the subpoena are (i) relevant, (ii) admissible, and (iii) specifically identified. Nixon, 418 U.S. at 700, 94 S.Ct. 3090; see also United States v. Yudong Zhu, 13-cr-761, 2014 WL 5366107, at *2-3 (S.D.N.Y. Oct. 14, 2014) (recognizing Nixon's continuing applicability to defense subpoenas issued to third parties); United States v. Binday, 12-cr-152, 2013 WL 4494659, at *1 (S.D.N.Y. Aug. 15, 2013) (same). The materials sought by subpoena must also be "`not otherwise procurable reasonably in advance of trial by exercise of due diligence.'" United States v. Rajaratnam, 753 F.Supp.2d 317, 322 (S.D.N.Y. 2011) (quoting Nixon, 418 U.S. at 699-700, 94 S.Ct. 3090).
To satisfy these requirements, "[t]he items sought cannot merely be potentially relevant or admissible. Rather, they must be shown to be relevant and admissible at the time the subpoena is sought." United States v. Barnes, 04-cr-186, 2008 WL 9359654, at *3 (S.D.N.Y. Apr. 2, 2008). What is more, the targeted "materials must themselves be admissible evidence"; that they merely "contain information which could be admissible" is insufficient. United States v. Cherry, 876 F.Supp. 547, 552 (S.D.N.Y. 1995). "Rule 17(c) subpoenas are not tools of discovery in criminal cases," United States v. Nektalov, 03-cr-828, 2004 WL 1574721, at *2 (S.D.N.Y. Jul. 14, 2004) (citing Bowman Dairy Co. v. United States, 341 U.S. 214, 220, 71 S.Ct. 675, 95 S.Ct. 879 (1951)), and, accordingly, they are not to be used as "general fishing expedition[s]," Nixon, 418 U.S. at 700, 94 S.Ct. 3090 (internal quotation marks omitted); see also United States v. Ferguson, 3:06-cr-137, 2008 WL 113663, at *1 (D. Conn. Jan. 2, 2008) (Rule
As noted above, the Court has already determined in ex parte proceedings that the Subpoena — as modified in light of the overbreadth and admissibility concerns articulated upon Wey's original application — satisfies the requirements of Rule 17(c). See December 15 Order. Nasdaq's limited objections in this regard do not move the Court to reconsider that conclusion. Nasdaq contends primarily that the information Wey requests is irrelevant (and thus inadmissible) because, while "Nasdaq's consideration and handling of the Issuers' listing applications may be part of the narrative of this case ... there is no reason to think that Wey's guilt or innocence could turn on the details of Nasdaq's decision-making." Br. at 10-11. It also urges that that many of the documents at issue are "likely already in the possession of the Issuers," which Wey himself purportedly controls, or available from the SEC, to which Nasdaq submitted records in connection with two of the Issuers' appeals of subsequent de-listing decisions. As such, Nasdaq avers, they are procurable by means other than the Subpoena. The Court disagrees on both counts.
"Generally, relevant evidence — that which has any tendency to make the existence of any fact that is of consequence to the determination of the action more probable or less probable — is admissible for all purposes except as provided otherwise by the Constitution or by Act of Congress." United States v. Griffith, 385 F.3d 124, 126 (2d Cir. 2004) (internal quotation marks, citation and brackets omitted) (citing Fed. R. Evid. 401-402). The Indictment, as discussed above, alleges that Wey, as part of a scheme to manipulate the demand for and price of Issuer stock, successfully deceived Nasdaq into concluding that the Issuers satisfied the 300 round-lot shareholder requirement by, among other things, gifting shares to confederates in order to artificially inflate investor bases. The Court has no difficulty concluding that evidence potentially suggesting that Nasdaq had actual knowledge that Wey was facilitating satisfaction of listing standards in this manner could be "of consequence" to a determination as to whether Wey engaged in deceptive conduct and thus whether he may be guilty of, for example, securities fraud. It would thus be admissible under the general standard set forth above. The Court is aware of no authority for the proposition that, to be admissible in a criminal case, evidence must be of such variety that the defendant's "guilt or innocence could turn on" it, Br. at 10-11, and it will not impose such a restrictive requirement here.
Finally, notwithstanding Nasdaq's speculative suggestion to the contrary, the Court sees no reason to conclude on the record before it that the materials that Nasdaq specifically objects to producing — which, as Wey notes in opposition, are largely "internal Nasdaq communications," Opp. at 14 (emphasis added) — would be reasonably available from the Issuers or from the SEC. Indeed, Nasdaq's only representations on this issue stop well short of credibly suggesting as much, noting without elaboration that Nasdaq submitted unspecified "records" to the SEC in the course of the de-listing appeals and that "many" of those records are "presumably" available to Wey. Br. at 11.
The Court concludes that quashing the Subpoena for failure to satisfy Rule 17(c) is unwarranted.
For the reasons set forth above, Nasdaq's motion to quash is DENIED. Nasdaq shall respond to the Subpoena within 30 days of this Order, or on any such date to which Nasdaq and Wey may agree.
This resolves Dkt. No. 89.
SO ORDERED.
